Tolmar Pharmaceuticals

Tolmar Pharmaceuticals continuously dedicates itself to technological and scientific research, enhancing patient care and creating value through innovative therapies and services. Tolmar’s product portfolio includes specialty products in urology, oncology, and dermatology. The invention of ELIGARD® (leuprolide acetate for injectable suspension) has gained global recognition, providing convenience to the urology, oncology, and hospital communities, healthcare providers, and patients. Technology-driven development and high-quality manufacturing capabilities have established Tolmar as a leader in topical generic drugs in the field of dermatology. With numerous FDA-approved products, the company has earned a global reputation for its strict standards, manufacturing expertise, and regulatory and clinical development.